Provides that the New York state health care quality and cost containment commission shall: evaluate each mandated benefit; investigate current practices of health plans with regard to the mandated benefit; investigate the potential premium impact of repealing and/or modifying the mandated benefits on all segments of the insurance market; hold at least two public hearings; submit a report to the legislature; makes related provisions.
This bill expands and revises the duties of the New York State Health Care Quality and Cost Containment Commission, a body within the Department of Insurance that reviews health insurance mandated benefits. It keeps the commission’s existing role of evaluating proposed mandated benefits, but changes the standard so that, when requested by the governor or the chairs of the Senate and Assembly insurance committees, the commission must evaluate the proposal rather than merely may do so. The bill also requires the commission to consider evidence-based medicine from peer-reviewed medical literature, the potential premium impact across the insurance market, and the potential cost to the state in light of the federal Affordable Care Act.
In addition to reviewing proposed new mandates, the bill adds a new recurring review process for existing state laws that require health benefits to be offered or made available in individual and group health insurance policies and health service plans. Beginning no later than nine months after the commission is seated and then at least every three years, the commission must analyze the cost and quality effects of all mandated benefits, hold at least two public hearings, and develop recommendations for repeal or modification where appropriate. The commission must then submit those recommendations, along with implementing legislation, to the Legislature and the public by February 1, 2026.
The bill would affect the Insurance Law by strengthening the commission’s authority, broadening its review responsibilities, and creating a formal process for periodic reassessment of mandated health insurance benefits. It also sets procedural requirements for legislative action on the commission’s recommendations, including introduction of implementing legislation without amendment and a timeline for votes in both houses. Health insurers, health plans, employers, consumers, providers, and policymakers would all be affected because the bill is aimed at identifying mandates that may increase premiums or otherwise affect coverage costs and quality.
The overall sentiment reflected by the bill text is cost-containment oriented and generally skeptical of the cumulative impact of mandated benefits on premiums, while still preserving a role for consumer and medical input. There are no recorded committee transcripts or votes in the provided material, so there is no direct evidence of support or opposition from debate. The structure of the bill suggests an emphasis on evidence-based review and legislative efficiency, but also a willingness to revisit and potentially repeal or modify existing benefit mandates.
The main point of contention is likely to be whether the commission should be required to recommend repeal or modification of mandated benefits and whether the Legislature should be constrained to act on those recommendations without amendment. Supporters may view the bill as a way to control health care costs and improve evidence-based policymaking, while opponents may worry it could weaken consumer protections, reduce required coverage, or shift decision-making away from the normal legislative process. Another likely issue is the bill’s focus on premium impact versus access to care and the adequacy of the commission’s composition and expertise.
The bill amends Section 213 of the Insurance Law governing the New York State Health Care Quality and Cost Containment Commission. It changes the commission’s mandate from optional review of proposed mandated benefits to mandatory review when requested by specified officials, adds explicit evidence-based and premium-impact criteria, and creates a new recurring obligation to review all existing mandated-benefit laws every three years. It also requires the commission to produce recommendations for repeal or modification and to provide implementing legislation, which would then be fast-tracked for introduction and floor votes in both legislative houses.
The bill’s apparent policy direction is cost containment, with a strong emphasis on analyzing whether mandated health insurance benefits raise premiums and whether they are supported by credible medical evidence. Because there are no committee transcripts or recorded votes in the provided context, there is no documented public debate to gauge support or opposition. Based on the text alone, the bill appears designed to appeal to lawmakers concerned about affordability and regulatory review, while likely drawing concern from those prioritizing coverage mandates and consumer protections.
The most likely points of contention are the bill’s requirement that the commission evaluate existing mandated benefits for possible repeal or modification, and the procedural requirement that implementing legislation be introduced and voted on without amendment. Critics may argue this narrows legislative discretion and could lead to reductions in required health coverage, while supporters may argue it is necessary to control insurance costs and ensure mandates are evidence-based. The bill also raises potential disagreement over how much weight should be given to premium impacts versus health outcomes and access to care, and over whether the commission’s composition and outside consultants can fairly represent consumers, providers, and insurers.